Report Information More information from: https://www.wiseguyreports.com/reports/456549
Next generation cancer diagnostics - Global Market Outlook (20152022) Report / Search Code: WGR456549
Price
1-user PDF : $ 4150.0
Description:
Publish Date: 1 March, 2016
1-5 User PDF : $ 5250.0
Enterprise PDF : $ 7500.0
According to Stratistics MRC, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region. Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-achip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot. Cancer Type Covered: • Lung Cancer • Colorectal Cancer • Cervical Cancer • Breast Cancer • Other Cancer Types Functions Covered: • Therapeutic Monitoring • Risk analysis • Prognostics diagnosis • Companion Diagnostics • Cancer Screening Technologies Covered: • Platform-Based Diagnostics o Polymerase Chain Reaction (PCR) o Next-Generation Sequencing (NGS) o Microarrays o In Situ Hybridization (ISH) o Immunohistochemistry (IHC) o Flow Cytometry o Other Technologies • Instrument-Based o Diagnostic Imaging o Ultrasound o Mammography • Biopsies Regions Covered: • North America o US o Canada o Mexico • Europe o Germany